Insufficient scRNA-seq data for expression of HARS2 at single-cell level.
Insufficient scRNA-seq data for expression of HARS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2123.47 | 1445 / 1445 | 100% | 17.62 | 183 / 183 |
skin | 100% | 2284.88 | 1809 / 1809 | 100% | 28.34 | 472 / 472 |
stomach | 100% | 1830.02 | 359 / 359 | 100% | 22.83 | 286 / 286 |
uterus | 100% | 2750.87 | 170 / 170 | 100% | 29.00 | 459 / 459 |
breast | 100% | 2350.52 | 459 / 459 | 100% | 34.66 | 1117 / 1118 |
lung | 100% | 1977.25 | 577 / 578 | 100% | 22.96 | 1155 / 1155 |
bladder | 100% | 2387.48 | 21 / 21 | 100% | 27.22 | 503 / 504 |
prostate | 100% | 2520.04 | 245 / 245 | 100% | 21.22 | 501 / 502 |
kidney | 100% | 2130.11 | 89 / 89 | 100% | 28.21 | 899 / 901 |
brain | 100% | 1837.32 | 2634 / 2642 | 100% | 25.90 | 705 / 705 |
thymus | 100% | 2499.10 | 653 / 653 | 100% | 25.05 | 603 / 605 |
intestine | 100% | 2489.19 | 966 / 966 | 99% | 28.39 | 523 / 527 |
pancreas | 100% | 1048.71 | 327 / 328 | 99% | 26.77 | 177 / 178 |
liver | 100% | 1130.63 | 226 / 226 | 99% | 18.47 | 402 / 406 |
adrenal gland | 100% | 2578.72 | 258 / 258 | 99% | 21.57 | 227 / 230 |
ovary | 100% | 2450.61 | 180 / 180 | 98% | 14.44 | 421 / 430 |
adipose | 100% | 2137.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.67 | 29 / 29 |
spleen | 100% | 3110.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.40 | 45 / 45 |
blood vessel | 100% | 1952.06 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1999.91 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1655.44 | 856 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 23.50 | 79 / 80 |
peripheral blood | 94% | 1427.93 | 871 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006412 | Biological process | translation |
GO_0006427 | Biological process | histidyl-tRNA aminoacylation |
GO_0006418 | Biological process | tRNA aminoacylation for protein translation |
GO_0005739 | Cellular component | mitochondrion |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0004821 | Molecular function | histidine-tRNA ligase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HARS2 |
Protein name | histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) Histidyl-tRNA synthetase Histidyl-tRNA synthetase 2, mitochondrial Histidine--tRNA ligase, mitochondrial (EC 6.1.1.21) (Histidine--tRNA ligase-like) (Histidyl-tRNA synthetase) (HisRS) |
Synonyms | HO3 HARSL HARSR |
Description | FUNCTION: Mitochondrial aminoacyl-tRNA synthetase that catalyzes the ATP-dependent ligation of histidine to the 3'-end of its cognate tRNA, via the formation of an aminoacyl-adenylate intermediate (His-AMP). . |
Accessions | B4DQ67 ENST00000448069.2 A0A2R8Y6I1 D6RJE6 ENST00000509299.6 ENST00000645749.1 [P49590-1] P49590 ENST00000642452.1 D6R9M5 ENST00000510104.5 ENST00000520095.6 A0A2R8Y3N3 A0A2R8Y5P7 ENST00000230771.9 [P49590-1] A0A2R8Y4X6 ENST00000503873.6 ENST00000643996.1 A0A2R8Y5E8 D6RB22 ENST00000647484.1 ENST00000646468.1 ENST00000642970.1 ENST00000508522.5 [P49590-2] ENST00000645065.1 ENST00000642752.1 |